1·We conducted a trial to analyze the efficacy and safety of voriconazole in the prevention of lung infiltrates during induction chemotherapy for acute myelogenous leukaemia (AML).
我们进行了一项临床试验旨在分析伏立康唑在急性髓细胞白血病化疗诱导阶段预防肺部浸润的有效性和安全性。
2·Inflammatory infiltrates are scant if any.
即使有炎症浸润也很少。
3·This muscular artery demonstrates vasculitis with chronic inflammatory cell infiltrates.
肌性动脉有慢性炎性细胞浸润的血管炎存在。
4·Primary efficacy parameter was the incidence of lung infiltrates until day 21 after initiation of chemotherapy.
主要的有效指标为化疗开始后21天肺部浸润的发病率。
5·Belongs to one kind of allergy syndrome, infiltrates at the same time periphery in the blood take the lungs the oxyphil markup as the characteristic.
属于一种变态反应性综合征，以肺部浸润同时周围血中嗜酸细胞增高为特征。